NCT01551615View on ClinicalTrials.gov

A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

Metformin 1000 mg

2 x 500 mg oral tablets

DRUG

Vandetanib 800 mg

2 x 300 mg and 2 x 100 mg oral tablets

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01551615 - A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib | Biotech Hunter | Biotech Hunter